This is a working overview of LC-MS/MS, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-18. Anything still debated is marked as such rather than presented as settled.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
| Property | Value | Notes |
|---|---|---|
| WADA classification | S4 Hormone and Metabolic Modulators | Prohibited at all times in sport. |
| Drug approval status | Not approved in major jurisdictions | No accepted therapeutic indication. |
| Common detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Typical test matrix | Urine or blood | Urine is common in anti-doping testing. |
| Product labeling | Research chemical or supplement | Often not independently verified. |
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
The categorization of amylopectin began with the first observation in starch in 1716 by Antonie van Leeuwenhoek, where he differentiated starch into two fundamental structural components. The terms amylose and amylopectin were not coined until 1906, by French researchers Maquenee and Roux in the course of an examination of starch, where they explained variations in the properties of starches according to the mixture of these related substances and variable saccharification by malt extract. Since then and through the 1940s, research focused on various methods of separation, like fractional precipitation or enzymatically. This gave rise to the Meyer definition of amylose and "reserv[ing] the name amylopectin to carbohydrates that are branched molecule, degraded by b-amylase only to the stage of residual dextrin". Meyer also proposed the tree like structure model for amylopectin. The currently accepted structural model was proposed in 1972, based on the cluster organization of double helical structures. Other models have been proposed since, such as the Bertoft BB model, or building block and backbone model in 2012. This model claims short chains are the structural building blocks and long chains the backbone to carry the building blocks, and that the different lengths of chain are separated by their position and direction of elongation.
Super Mario Bros. (originally released in 1985) In Edge's 10th anniversary issue in 2003, GoldenEye 007 (1997) was included as one of the magazine's top ten shooters, along with a note that it was perhaps "the only other game" that should have received a ten out of ten rating. The game had originally been awarded a nine out of ten, with the magazine later stating that "a ten was considered, but eventually rejected". Resident Evil 4, which came second in Edge Presents The 100 Best Videogames, originally obtained a nine, but according to the 100 Best Videogames issue, it came "as near as dammit to the sixth (at the time) Edge ten". The 20th anniversary issue (E258) published in August 2013 carried a feature called "The Ten Amendments", in which the following seven games' scores were retrospectively adjusted to ten-out-of-ten. A rationale was provided for each.
=== Pharmacodynamics === BMS-986122 can enhance the affinity and efficacy of various orthosteric MOR agonists, including the endogenous opioid peptides, for the MOR. However, its effects are dependent on the ligand, and in the case of morphine, it enhances efficacy without affecting affinity. BMS‐986122 has no MOR agonist activity, is selective for the MOR, and lacks PAM activity at the δ-opioid receptor (DOR). However, it has been identified as a silent allosteric modulator (SAM) of the DOR and κ-opioid receptor (KOR). The drug has analgesic effects in animals. In contrast to MOR agonists, BMS-986122 does not appear to promote opioid-induced constipation, respiratory depression, or reward. The drug has been found to attenuate opioid tolerance in rodents, specifically in terms of analgesia. Besides its analgesic effects, BMS-986122 has been found to enhance the analgesic effects of non-opioid analgesics such as clonidine and gabapentin in rodents.
=== Local boards and sanitary districts === Outside of municipal boroughs, there was no effective local government until the 1840s. In response to poor sanitary conditions and outbreaks of cholera, the Public Health Act 1848 (11 & 12 Vict. c. 63) and the Local Government Act 1858 allowed for the formation of local boards of health in populous areas. Local boards were responsible among other things for water supply, drainage, sewerage, paving and cleansing. Eleven local boards were initially formed at Brampton, Cleator Moor, Cockermouth, Egremont, Holme Cultram, Keswick, Maryport, Millom, Penrith, Whitehaven, Wigton and Workington. Further reform under the Public Health Act 1875 (38 & 39 Vict. c. 55) saw the creation of sanitary districts throughout England and Wales. The existing municipal boroughs and local boards became "urban sanitary districts", while "rural sanitary districts" were formed from the remaining areas of the poor law unions. Three more local boards were formed: Arlecdon and Frizington in 1882, Harrington in 1891 and Aspatria in 1892. In addition Workington and Whitehaven received charters of incorporation to become municipal boroughs in 1883 and 1894 respectively.
Sources: en.wikipedia.org
=== Additives === The mechanical properties of hydrogels can be fine-tuned in many ways beginning with attention to their hydrophobic properties. Another method of modifying the strength or elasticity of hydrogels is to graft or surface coat them onto a stronger/stiffer support, or by making superporous hydrogel (SPH) composites, in which a cross-linkable matrix swelling additive is added. Other additives, such as nanoparticles and microparticles, have been shown to significantly modify the stiffness and gelation temperature of certain hydrogels used in biomedical applications.
== Structure == Spiroligomer molecules can be synthesized in any direction, and between any pair of bis-amino acids. Spiroligomer diketopiperazines can be created between either end of a bis-amino acid. Spiroligomer molecules are known to be conformationally rigid, due to the fused-ring backbone.
=== Receptor endocytosis === Activated RTKs can undergo endocytosis resulting in down regulation of the receptor and eventually the signaling cascade. The molecular mechanism involves the engulfing of the RTK by a clathrin-mediated endocytosis, leading to intracellular degradation.
Sources: en.wikipedia.org
Negros (English: , UK: , Tagalog: [ˈnegɾos]) is the fourth largest and third most populous island in the Philippines, with a total land area of 13,309 km2 (5,139 sq mi). The coastal zone of the southern part of Negros is identified as a site of highest marine biodiversity importance in the Coral Triangle. Negros is one of the many islands of the Visayas, in the central part of the country. The predominant inhabitants of the island region are mainly called Negrenses (locally Negrosanons). As of 2024 census, the total population of Negros is 4,797,302 people. This puts it among the 25 most populous islands in the world, close in population to Sicily or Bali. From 2015 to 2017, the whole island was governed as an administrative region officially named the Negros Island Region, which comprised the highly urbanized city of Bacolod and the provinces of Negros Occidental and Negros Oriental, along with its corresponding outlying islands and islets within a total regional area of 13,350.74 km2 (5,154.75 sq mi). It was created on May 29, 2015, by virtue of Executive Order No. 183 issued by President Benigno Aquino III. On August 9, 2017, the region was dissolved after President Rodrigo Duterte signed Executive Order No. 38, reverting its constituents to their previous regions. On June 13, 2024, Negros island together with neighboring Siquijor were grouped together under a reconstituted Negros Island Region with Republic Act No. 12000 signed by President Bongbong Marcos.
== Production == Approximately 1.5 million tons were produced in 1985, typically by the reaction of potassium chloride with sulfuric acid, analogous to the Mannheim process for producing sodium sulfate. The process involves intermediate formation of potassium bisulfate, an exothermic reaction that occurs at room temperature:
=== Recycling === Nylons is typically used in durable goods, so it makes only a minor contribution to waste streams. Nylons are susceptible to hydrolysis, but the process is slow at room temperature and neutral pH, hence the utility of these materials. Being a robust polymer, nylon resin waste is not often recycled. The rate of hydrolysis increases in the presence of strong acids, a reaction essentially the reverse of their synthesis. Nylons are also the most popular fiber type in the residential carpet industry today. The US EPA estimates that 9.2% of carpet fiber, backing and padding was recycled in 2018, 17.8% was incinerated in waste-to-energy facilities, and 73% was discarded in landfills. Discarded nylon fishing gear such as fishing nets contributes to debris in the ocean. Its production however can use a closed loop during manufacturing, by grinding sprues and runners and mixing them with the virgin granules being consumed by the molding machine. The process of recycling post-consumer nylon waste is expensive and difficult, so few companies utilize it, favoring cheaper newly made plastics for their products instead. US clothing company Patagonia has sold products containing recycled nylon and in the mid-2010s invested in Bureo, a company that recycles nylon from used fishing nets to make sunglasses and skateboards. The Italian company Aquafil has also recycled nylon from fishing nets, to create apparel. Vanden Recycling recycles nylon and other polyamides (PA) and has operations in the UK, Australia, Hong Kong, the UAE, Turkey and Finland.
== Career == In 1996 Davidson proposed that the level of a person's HbA1c—a measure of average blood glucose—could be used to diagnose diabetes mellitus. The American Diabetes Association and the World Health Organization agreed in 2010 and recommended its use for diagnosis. Davidson is a past president of the American Diabetes Association, a past Editor-in-Chief of Diabetes Care and the founding editor of Current Diabetes Reports. He is the author of more than 170 scientific articles. Wiley Medical Education published Davidson's first book, Diabetes Mellitus: Diagnosis and Treatment, in four editions beginning in 1981. Saunders (now Elsevier) published a fifth edition co-authored by Anne Peters Harmel and Ruchi Mathur, in 2003, renaming the book Davidson's Diabetes Mellitus: Diagnosis and Treatment. The American Diabetes Association published Meeting the American Diabetes Association Standards of Care: An Algorithmic Approach to Clinical Care of the Diabetes Patient in 2010. The title is in its second edition, published in 2017. With Debra L. Gordon, Davidson wrote two editions of The Complete Idiot's Guide to Type 2 Diabetes. In 1970 Philip Rossman and Mayer Davidson founded the Venice Family Clinic, a free clinic in the Venice neighborhood of Los Angeles. By the mid-1990s, it had grown to be the largest free medical clinic in the country. It is now a UCLA-affiliated community clinic with 12 locations. He is now chief medical officer of Mellitus Health.
Sources: en.wikipedia.org
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.
Legality varies by country and context. It lacks marketing approval as a medicine in major countries. Sports organizations prohibit its use at all times.
A certificate of analysis may report identity, purity, and testing methods for a specific batch. It does not guarantee safety or legal status. Independent verification can confirm whether the material matches the label.
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.